Virax Biolabs Expands Mpox Test Distribution Agreement with Cosmos Health
Virax Biolabs extended its distribution agreement with Cosmos Health to commercialize its Mpox kits in the Gulf Cooperation Council.
Read MorePosted by Andy Lundin | Sep 16, 2024 | Emerging & Zoonotic Diseases |
Virax Biolabs extended its distribution agreement with Cosmos Health to commercialize its Mpox kits in the Gulf Cooperation Council.
Read MorePosted by Andy Lundin | Sep 10, 2024 | Sexually Transmitted Diseases |
An emergency department dramatically increased screening and diagnosis rates for syphilis by offering optional tests for the STI.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Emerging & Zoonotic Diseases |
ID-FISH Technology’s new test for the detection of IgG antibodies against Borrelia-causing Lyme disease has received FDA clearance.
Read MorePosted by Andy Lundin | Sep 3, 2024 | Miscellaneous, Sexually Transmitted Diseases |
The NIAID has awarded grants for 10 projects aimed at developing advanced diagnostic tools for congenital and adult syphilis.
Read MorePosted by Andy Lundin | Sep 3, 2024 | Company News |
Seegene and Springer Nature launched a global initiative that empowers researchers to develop innovative diagnostic assays.
Read More